ESC 2026 DiscussionExplore the Hot Line trials, expert perspectives, and key takeawaysExplore the discussion→Papers from every journal, all in one place. Create custom feeds.
Direct transfer associated with lower OHCA mortality; hypothesis-generating and requires randomized confirmation before practice change.

No consistent aspiration risk elevation supports continuing GLP-1 RAs perioperatively; leaves open need for RCTs given low-certainty evidence.

Supports acute PVI feasibility with pear two-step PFA in this cohort; leaves open durability, safety, and efficacy for randomized trials.

Supports culprit optimization in contemporary AMI practice; leaves open optimal non-culprit strategies in multivessel disease.
May support expanded DCM genetic testing panels; extends prior ClinGen curation for clinical and research use.
These standards should raise preclinical cardio-oncology research quality; extends consensus by defining essential versus desirable benchmarks for models.

Transaxillary TAVI access was associated with comparable early safety and lower bleeding in this cohort; leaves open randomized confirmation before altering practice.

May inform preoperative risk stratification in orthopedic surgery; hypothesis-generating pending prospective validation and outcome trials.
May support GWI for early CTRCD risk stratification before LVEF decline; hypothesis-generating and requires prospective validation.

Efficiency gains with newer AF ablation technologies may aid workflow and radiation safety; leaves open causal effects on outcomes and generalizability.
